IQVIA Holdings Inc (IQV) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Total Revenue Chart for IQVIA Holdings Inc

IQVIA Holdings Inc (IQV) revenue for FY2025 was USD 16.3B, a 5.9% change from FY2024. IQVIA Holdings Inc's revenue grew from USD 3.9B in 2010 to USD 16.3B in 2025 (315.6% over 15 years). Earnings per share grew from USD 1.90 in 2011 to USD 7.84 in 2025 (313.5%). Revenue compound annual growth rate: 5-year CAGR of 7.5%, 10-year CAGR of 11.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$38.26B
Implied Share Price
$232.43
Enterprise Value
$52.85B
Revenue (TTM)
$16.98B
EBITDA
$3.05B
Profit Margin
8.10%
Trailing P/E
28.91
Forward P/E
18.25
Price/Book (MRQ)
6.27
Price/Sales (TTM)
2.25
EV/EBITDA
14.98
EV/Revenue
3.11
Dividend Yield
—
Book Value
$37.49
Free Cash Flow (FY2025)
$2.05B
Free Cash Flow Yield
5.36%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.